{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:29:32Z","timestamp":1793860172151,"version":"4.6.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11730-z","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:53:22Z","timestamp":1790344402000},"page":"11243-11264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4300-0142","authenticated-orcid":false,"given":"Nashwa H.","family":"Zaher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M. M.","family":"El-Hazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed I.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"11730_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108945","author":"P Balakumar","year":"2026","unstructured":"Balakumar P, Mulukuri NVLS, Jagadeesh G (2026) A map of molecular drug targets and therapeutics for the US FDA-approved drugs: the impact of expedited regulatory pathways and first-in-class drug approvals on drug innovation. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108945","journal-title":"Pharmacol Ther"},{"key":"11730_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.afres.2025.101127","volume":"5","author":"S Kaur","year":"2025","unstructured":"Kaur S, Gadpayale D, Kumari A, Kaur G, Kumar A, Seem K, Bhardwaj R, Riar A (2025) Antidiabetic potential of underutilized crops: nutritional, phytochemical insights, and prospects for diabetes management. Appl Food Res 5:101127","journal-title":"Appl Food Res"},{"key":"11730_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09132-3","author":"TH Wang","year":"2020","unstructured":"Wang TH, Zhou XF, Ni Y, Pan ZG (2020) Health information needs regarding diabetes mellitus in China: an internet-based analysis. BMC Public Health. https:\/\/doi.org\/10.1186\/s12889-020-09132-3","journal-title":"BMC Public Health"},{"key":"11730_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.bbrc.2020.10.040","volume":"534","author":"J Lee","year":"2021","unstructured":"Lee J, Tsogbadrakh B, Yang SH, Ryu H, Kang E, Kang M, Kang HG, Ahn C, Oh KH (2021) Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1\u03b1-mediated renal mitochondrial protection. Biochem Biophys Res Commun 534:1040","journal-title":"Biochem Biophys Res Commun"},{"key":"11730_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/IJNRD.S40172","volume":"7","author":"AKH Lim","year":"2014","unstructured":"Lim AKH (2014) Diabetic nephropathy\u2014complications and treatment. Int J Nephrol Renovasc Dis 7:361","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"11730_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41598-017-00305-6","volume":"7","author":"Y Fan","year":"2017","unstructured":"Fan Y, Zhang J, Xiao W, Lee K, Li Z, Wen J, He L, Gui D, Xue R, Jian G, Sheng X, He JC, Wang N (2017) Rtn1a-mediated endoplasmic reticulum stress in podocyte injury and diabetic nephropathy. Sci Rep 7:323","journal-title":"Sci Rep"},{"key":"11730_CR7","volume-title":"Bioactive food components activity in mechanistic approach","author":"MV Geraldi","year":"2021","unstructured":"Geraldi MV, Loubet Filho PS, Baseggio AM, Cazarin CBB, Marostica Junior MR (2021) Chapter 2\u2014Main molecular mechanisms for noncommunicable diseases. Bioactive food components activity in mechanistic approach, vol 5"},{"key":"11730_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274794","volume":"17","author":"YK Kim","year":"2022","unstructured":"Kim YK (2022) Comparing the long non-coding RNA expression profiles of skeletal muscle and kidney tissues from patients with diabetes. PLoS ONE 17:e0274794","journal-title":"PLoS ONE"},{"key":"11730_CR9","doi-asserted-by":"publisher","first-page":"1602594","DOI":"10.3389\/fendo.2025.1602594","volume":"16","author":"G Hou","year":"2025","unstructured":"Hou G, Dong Y, Jiang Y, Zhao W, Zhou L, Cao S, Li W (2025) Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy. Front Endocrinol 16:1602594","journal-title":"Front Endocrinol"},{"key":"11730_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s13105-025-01092-9","volume":"81","author":"H Elsherbiny","year":"2025","unstructured":"Elsherbiny H, Alnasser SM, Aref M, ElSheikh E, El-sayed SF, El-Malkey NF, Alqahtani HA, Alghamdi AAA, Nassan MA, Abd-ELhafeez HH, Salem GA (2025) Spexin peptide ameliorates renal injury in diabetic nephropathy rat model via modulation of metabolic, oxidative, inflammatory, and apoptotic dysregulations. J Physiol Biochem 81:657","journal-title":"J Physiol Biochem"},{"key":"11730_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4274\/tji.galenos.2024.26213","volume":"12","author":"MSG Chahkand","year":"2024","unstructured":"Chahkand MSG, Tavakoli Y, Aghakhani A, Askarzadeh M, Azimi H, Ghalamkarpour N, Alizadeh A, Archin I, Kermani S, Ansari A, Poudineh M, Mali Z, Foroughi E, Erabi G, Mazhari SA, Fallahi MS, Deravi N, Dadkhah PA (2024) Toll-like receptors and diabetic nephropathy: a review of recent advances. Turk J Immunol 12:35","journal-title":"Turk J Immunol"},{"key":"11730_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.609223","author":"RH Aly","year":"2020","unstructured":"Aly RH, Ahmed AE, Hozayen WG, Rabea AM, Ali TM, El Askary A, Ahmed OM (2020) Patterns of Toll-Like receptor expressions and inflammatory cytokine levels and their implications in the progress of insulin resistance and diabetic nephropathy in type 2 diabetic patients. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2020.609223","journal-title":"Front Physiol"},{"key":"11730_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106940","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Liu C, Zhang Z, Chen J, Zhao D, Li L, Tong M, Zhang G (2023) Identification and validation of diagnostic biomarkers of coronary artery disease progression in type 1 diabetes via integrated computational and bioinformatics strategies. Comput Biol Med. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106940","journal-title":"Comput Biol Med"},{"key":"11730_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jare.2025.07.013","volume":"82","author":"Z Li","year":"2025","unstructured":"Li Z, Tan D, Lin J, Zhang T, Liu B, Zhao B, Liang D, Li L, Wei X, Lv Z, Wang R (2025) Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PKC\u03b4\/SHP-1-dependent ER stress and relieving podocyte damage and inflammation. J Adv Res 82:845","journal-title":"J Adv Res"},{"issue":"5","key":"11730_CR15","doi-asserted-by":"publisher","first-page":"e97985","DOI":"10.1371\/journal.pone.0097985","volume":"9","author":"J Ma","year":"2014","unstructured":"Ma J, Chadban SJ, Zhao CY, Chen X, Kwan T, Panchapakesan U, Pollock CA, Wu H (2014) TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS ONE 9(5):e97985","journal-title":"PLoS ONE"},{"key":"11730_CR16","doi-asserted-by":"publisher","first-page":"177543","DOI":"10.1016\/j.ejphar.2025.177543","volume":"998","author":"C Chen","year":"2025","unstructured":"Chen C, Xu B, Li W, Chen J, Yang M, Gao L, Zhou J (2025) New perspectives on the treatment of diabetic nephropathy: challenges and prospects of mesenchymal stem cell therapy. Eur J Pharmacol 998:177543","journal-title":"Eur J Pharmacol"},{"key":"11730_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.01.014","author":"J Wu","year":"2024","unstructured":"Wu J, Li K, Zhou M, Gao H, Wang W, Xiao W (2024) Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. J Pharm Anal. https:\/\/doi.org\/10.1016\/j.jpha.2024.01.014","journal-title":"J Pharm Anal"},{"key":"11730_CR18","doi-asserted-by":"publisher","first-page":"102856","DOI":"10.1016\/j.nano.2025.102856","volume":"69","author":"Y Wang","year":"2025","unstructured":"Wang Y, Shu H, Cheng G, Chun Zhou X, Gao H, Qi Z, Ma X, Zhang W, Wang J (2025) A novel treatment for diabetic nephropathy: Folate receptor-targeted delivery of TLR4 siRNA via functionalized PLGA nanoparticles in streptozotocin-induced diabetic murine models. Nanomedicine 69:102856","journal-title":"Nanomedicine"},{"key":"11730_CR19","doi-asserted-by":"publisher","first-page":"1592423","DOI":"10.3389\/fnut.2025.1592423","volume":"12","author":"AS Bedir","year":"2025","unstructured":"Bedir AS, Almasri RS, Al Raish SM (2025) Therapeutic efficacy of Nigella sativa and Ziziphus lotus: sustainable strategies for diabetes, antimicrobial resistance, and health treatment. Front Nutr 12:1592423","journal-title":"Front Nutr"},{"key":"11730_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.biopha.2019.01.006","volume":"111","author":"S Arjumand","year":"2019","unstructured":"Arjumand S, Shahzad M, Shabbir A, Yousaf MZ (2019) Thymoquinone attenuates rheumatoid arthritis by downregulating TLR2, TLR4, TNF-\u03b1, IL-1, and NF\u03baB expression levels. Biomed Pharmacother 111:958","journal-title":"Biomed Pharmacother"},{"key":"11730_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuro.2024.02.002","volume":"101","author":"B Zhao","year":"2024","unstructured":"Zhao B, Zhang S, Amin N, Pan J, Wu F, Shen G, Tan M, Shi Z, Geng Y (2024) Thymoquinone regulates microglial M1\/M2 polarization after cerebral ischemia-reperfusion injury via the TLR4 signaling pathway. Neurotoxicology 101:54","journal-title":"Neurotoxicology"},{"key":"11730_CR22","first-page":"e8390","volume":"12","author":"X Wang","year":"2020","unstructured":"Wang X, Jiang A, Batra V (2020) Severe thrombocytopenia associated with black seed oil and evening primrose oil. Cureus 12:e8390","journal-title":"Cureus"},{"key":"11730_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fphar.2017.00656","volume":"8","author":"SN Goyal","year":"2017","unstructured":"Goyal SN, Prajapati CP, Gore PR, Patil CR, Mahajan UB, Sharma C, Talla SP, Ojha SK (2017) Therapeutic potential and pharmaceutical development of thymoquinone: a multitargeted molecule of natural origin. Front Pharmacol 8:656","journal-title":"Front Pharmacol"},{"key":"11730_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.focha.2025.101053","volume":"8","author":"KS Nainawat","year":"2025","unstructured":"Nainawat KS, Budakoti A, Kumari N, Verma RS, Gupta A (2025) Pharmaceutical perspectives of thymoquinone, a lead molecule from black cumin (Nigella sativa L.) with diverse biological targets. Food Chem Adv 8:101053","journal-title":"Food Chem Adv"},{"key":"11730_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s11095-010-0145-3","volume":"27","author":"S Banerjee","year":"2010","unstructured":"Banerjee S, Azmi AS, Padhye S, Singh MW, Baruah JB, Philip PA, Sarkar FH, Mohammad RM (2010) Structure-activity studies on therapeutic potential of thymoquinone analogs in pancreatic cancer. Pharm Res 27:1146","journal-title":"Pharm Res"},{"key":"11730_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108837","author":"C Wei","year":"2025","unstructured":"Wei C, Cheng J, Zou H, Zheng M, Liu X, Du J, Jiang X, He J, Guo K, El-Far AH, Chen H, Fu J (2025) TQFL13, a novel synthetic derivative of thymoquinone (TQ), is more capable of inhibiting breast cancer progression than TQ. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108837","journal-title":"Bioorg Chem"},{"key":"11730_CR27","first-page":"e202304940","volume":"9","author":"H Beyaztas","year":"2024","unstructured":"Beyaztas H, Babaoglu B, Demirkol B, Cetinkaya E, Metin Guler E (2024) Synthesis and characterization of thymoquinone-oxime (TQ-Ox) from thymoquinone and evaluation of its cytotoxic, genotoxic, and apoptotic potential in lung cancer cells (A549) in vitro. Chem Select 9:e202304940","journal-title":"Chem Select"},{"key":"11730_CR28","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.3390\/molecules28104096","volume":"28","author":"EEM Eid","year":"2023","unstructured":"Eid EEM, Almaiman AA, Alshehade SA, Alsalemi W, Kamran S, Suliman FEO, Alshawsh MA (2023) Characterization of thymoquinone-sulfobutylether-\u03b2-cyclodextrin inclusion complex for anticancer applications. Molecules 28:4096","journal-title":"Molecules"},{"key":"11730_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13104-023-06523-8","volume":"16","author":"MY Mohammad","year":"2023","unstructured":"Mohammad MY, Haniffa HM, Choudhary MI (2023) Antibacterial activity of thymoquinone derivative. BMC Res Notes 16:260","journal-title":"BMC Res Notes"},{"key":"11730_CR30","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1080\/14786419.2023.2217705","volume":"38","author":"EM Guler","year":"2024","unstructured":"Guler EM, Bozali K (2024) Synthesised thymoquinone-oxime induces cytotoxicity, genotoxicity and apoptosis in hepatocellular cancer cells: in vitro study. Nat Prod Res 38:1695","journal-title":"Nat Prod Res"},{"key":"11730_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020433","author":"NK Isaev","year":"2023","unstructured":"Isaev NK, Genrikhs EE, Stelmashook EV (2023) Antioxidant thymoquinone and its potential in the treatment of neurological diseases. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12020433","journal-title":"Antioxidants"},{"key":"11730_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","volume":"458","author":"BS Park","year":"2009","unstructured":"Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO (2009) The structural basis of lipopolysaccharide recognition by the TLR4\u2013MD-2 complex. Nature 458:1191","journal-title":"Nature"},{"key":"11730_CR33","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1021\/acs.jmedchem.0c01104","volume":"64","author":"A Monastyrskyi","year":"2021","unstructured":"Monastyrskyi A, Brockmeyer F, Lacrue AN, Zhao Y, Maher SP, Maignan JR, Padin-Irizarry V, Sakhno YI, Parvatkar PT, Asakawa AH, Huang L, Casandra D, Mashkouri S, Kyle DE, Manetsch R (2021) Aminoalkoxycarbonyloxymethyl ether prodrugs with a pH-triggered release mechanism: a case study improving solubility, bioavailability, and efficacy of antimalarial 4(1H)-quinolones with single dose cures. J Med Chem 64:6581","journal-title":"J Med Chem"},{"key":"11730_CR34","first-page":"72","volume":"69","author":"F Lami","year":"2026","unstructured":"Lami F, Romerio A, Valle-G\u00f3mez L, Mart\u00edn-C\u00e1mara O, Mart\u00edn-Santamar\u00eda S, Peri F (2026) Validating natural compounds as toll-like receptor 4 (TLR4) antagonists: experimental challenges and therapeutic perspectives. J Med Chem 69:72","journal-title":"J Med Chem"},{"key":"11730_CR35","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.4049\/jimmunol.1401796","volume":"193","author":"M Oda","year":"2014","unstructured":"Oda M, Yamamoto H, Shibutani M, Nakano M, Yabiku K, Tarui T, Kameyama N, Shirakawa D, Obayashi S, Watanabe N, Nakase H, Suenaga M, Matsunaga Y, Nagahama M, Takahashi H, Imagawa H, Kurosawa M, Terao Y, Nishizawa M, Sakurai J (2014) Vizantin inhibits endotoxin-mediated immune responses via the TLR 4\/MD-2 complex. J Immunol 193:4507","journal-title":"J Immunol"},{"key":"11730_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1753425917695445","volume":"23","author":"K Tomb\u00e1cz","year":"2017","unstructured":"Tomb\u00e1cz K, Mwangi D, Werling D, Gibson AJ (2017) Comparison of cellular assays for TLR activation and development of a species-specific reporter cell line for cattle. Innate Immun 23:329","journal-title":"Innate Immun"},{"key":"11730_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jff.2012.10.014","volume":"5","author":"S Ahmad","year":"2013","unstructured":"Ahmad S, Beg ZH (2013) Alleviation of plasma, erythrocyte and liver lipidemic-oxidative stress by thymoquinone and limonene in atherogenic suspension fed rats. J Funct Foods 5:251","journal-title":"J Funct Foods"},{"key":"11730_CR38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s40200-021-00782-7","volume":"20","author":"S Kumari","year":"2021","unstructured":"Kumari S, Kamboj A, Wanjari M, Sharma AK (2021) Nephroprotective effect of vanillic acid in STZ-induced diabetic rats. J Diabetes Metab Disord 20:571","journal-title":"J Diabetes Metab Disord"},{"key":"11730_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1126272","author":"A Shaukat","year":"2023","unstructured":"Shaukat A, Zaidi A, Anwar H, Kizilbash N (2023) Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review. Front Nutr. https:\/\/doi.org\/10.3389\/fnut.2023.1126272","journal-title":"Front Nutr"},{"key":"11730_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","volume":"103","author":"S Rayego-Mateos","year":"2023","unstructured":"Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fern\u00e1ndez C, Marchant V, Donate-Correa J, Navarro-Gonz\u00e1lez JF, Ortiz A, Ruiz-Ortega M (2023) Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int 103:282","journal-title":"Kidney Int"},{"key":"11730_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01119","volume":"11","author":"AL Alaofi","year":"2020","unstructured":"Alaofi AL (2020) Sinapic acid ameliorates the progression of streptozotocin (STZ)-induced diabetic nephropathy in rats via NRF2\/HO-1 mediated pathways. Front Pharmacol 11:540139","journal-title":"Front Pharmacol"},{"key":"11730_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 93:137","journal-title":"Physiol Rev"},{"key":"11730_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.foodchem.2008.11.069","volume":"115","author":"G Pereira-Caro","year":"2009","unstructured":"Pereira-Caro G, Madrona A, Bravo L, Espartero JL, Alcudia F, Cert A, Mateos R (2009) Antioxidant activity evaluation of alkyl hydroxytyrosyl ethers, a new class of hydroxytyrosol derivatives. Food Chem 115:86","journal-title":"Food Chem"},{"key":"11730_CR44","first-page":"e70482","volume":"16","author":"B Butt","year":"2024","unstructured":"Butt B, Ghulam B, Bashir Z, Abbasi SR, Hussain S, Jadoon SK, Akbar A, Khan MA (2024) Enhanced creatinine level in diabetic patients maximizing the possibilities of nephropathy and its association with blood urea nitrogen and glomerular filtration rate. Cureus 16:e70482","journal-title":"Cureus"},{"key":"11730_CR45","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s10157-024-02537-z","volume":"28","author":"K Kanasaki","year":"2024","unstructured":"Kanasaki K, Ueki K, Nangaku M (2024) Diabetic kidney disease: the kidney disease relevant to individuals with diabetes. Clin Exp Nephrol 28:1213","journal-title":"Clin Exp Nephrol"},{"key":"11730_CR46","first-page":"905","volume":"16","author":"A Hofni","year":"2023","unstructured":"Hofni A, Ali FEM, Ibrahim ARN, Aboubaker EM (2023) Renoprotective effect of thymoquinone against streptozotocin-induced diabetic nephropathy: role of NOX2 and Nrf2 signals. Curr Mol Pharmacol 16:905\u2013914","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"11730_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpha.2023.09.003","volume":"14","author":"M Yang","year":"2024","unstructured":"Yang M, Zhang C (2024) The role of innate immunity in diabetic nephropathy and their therapeutic consequences. J Pharm Anal 14(1):39\u201351","journal-title":"J Pharm Anal"},{"key":"11730_CR48","doi-asserted-by":"publisher","first-page":"628289","DOI":"10.3389\/fmed.2020.628289","volume":"7","author":"J Donate-Correa","year":"2021","unstructured":"Donate-Correa J, Ferri CM, S\u00e1nchez-Quintana F, P\u00e9rez-Castro A, Gonz\u00e1lez-Luis A, Mart\u00edn-N\u00fa\u00f1ez E, Mora-Fern\u00e1ndez C, Navarro-Gonz\u00e1lez JF (2021) Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications. Front Med 7:628289","journal-title":"Front Med"},{"key":"11730_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s12272-025-01555-z","volume":"48","author":"BL Abhirami","year":"2025","unstructured":"Abhirami BL, Krishna AA, Kumaran A, Chiu CH (2025) Targeting NF-\u03baB in diabetic nephropathy: exploring the therapeutic potential of phytoconstituents. Arch Pharm Res 48:577","journal-title":"Arch Pharm Res"},{"key":"11730_CR50","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Tumarin J, Prabhakar S (2024) Role of inflammation in the progression of diabetic kidney disease. Vessel Plus 8","DOI":"10.20517\/2574-1209.2024.21"},{"key":"11730_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262311637","author":"M Guo","year":"2025","unstructured":"Guo M, Ni L, Wu X (2025) Natural products as potential therapeutic candidates for diabetic kidney disease: molecular mechanisms, translational challenges, and future prospects. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms262311637","journal-title":"Int J Mol Sci"},{"key":"11730_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294142","author":"M Wyczanska","year":"2023","unstructured":"Wyczanska M, Rohling J, Keller U, Benz MR, Kirschning C, Lange-Sperandio B (2023) TLR2 mediates renal apoptosis in neonatal mice subjected experimentally to obstructive nephropathy. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0294142","journal-title":"PLoS ONE"},{"key":"11730_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123307","author":"SM Selim","year":"2025","unstructured":"Selim SM, El Fayoumi HM, El-Sayed NM, Mehanna ET, Hazem RM (2025) Alogliptin attenuates STZ-induced diabetic nephropathy in rats through the modulation of autophagy, apoptosis, and inflammation pathways: targeting NF-\u03baB and AMPK\/mTOR pathway. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2024.123307","journal-title":"Life Sci"},{"key":"11730_CR54","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.2147\/DMSO.S274844","volume":"13","author":"AS Yehualashet","year":"2020","unstructured":"Yehualashet AS (2020) Diabetes, Toll-like receptors as a potential drug target for diabetes mellitus and diabetes-associated complications. Metab Syndr Obes 13:4763","journal-title":"Metab Syndr Obes"},{"key":"11730_CR55","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ndt\/gft446","volume":"29","author":"M Lin","year":"2014","unstructured":"Lin M, Tang SCW (2014) Toll-like receptors: sensing and reacting to diabetic injury in the kidney. Nephrol Dial Transpl 29:746","journal-title":"Nephrol Dial Transpl"},{"key":"11730_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47110885","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang C, Fu Y, Xie L, Kong Y, Yang X (2025) Inflammation, apoptosis, and fibrosis in diabetic nephropathy: molecular crosstalk in proximal tubular epithelial cells and therapeutic implications. Curr Issues Mol Biol. https:\/\/doi.org\/10.3390\/cimb47110885","journal-title":"Curr Issues Mol Biol"},{"key":"11730_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.155940","volume":"269","author":"H Malathi","year":"2025","unstructured":"Malathi H, Khandelwal G, Gayathri S, Sahoo S, Sharma S (2025) Toll-like receptors in kidney ischemia-reperfusion injury: modulating macrophage responses for therapeutic insights. Pathol Res Pract 269:155940","journal-title":"Pathol Res Pract"},{"key":"11730_CR58","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s42003-025-08424-x","volume":"8","author":"A Mansouri","year":"2025","unstructured":"Mansouri A, Akthar I, Miyamoto A (2025) TLR2 and TLR4 bridge physiological and pathological inflammation in the reproductive system. Commun Biol 8:1008","journal-title":"Commun Biol"},{"key":"11730_CR59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.59278\/cbs.v4i10.65","volume":"4","author":"G Farmaning Putri","year":"2025","unstructured":"Farmaning Putri G, Nurfatihah Z (2025) Bax\/Bcl-2 ratio as the golden marker of apoptosis: molecular mechanisms and regulatory pathways. Int J Cell Biomed Sci 4:309","journal-title":"Int J Cell Biomed Sci"},{"key":"11730_CR60","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.radphyschem.2010.04.014","volume":"79","author":"BK Singh","year":"2010","unstructured":"Singh BK, Parwate DV, Sarma IBD, Shukla SK (2010) Study on gamma and electron beam sterilization of third generation cephalosporins cefdinir and cefixime in solid state. Radiat Phys Chem 79:1079","journal-title":"Radiat Phys Chem"},{"key":"11730_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejbt.2016.11.009","volume":"25","author":"P Zalewski","year":"2017","unstructured":"Zalewski P, Skibi\u0144ski R, Szymanowska-Powa\u0142owska D, Piotrowska H, Bednarski W, Cielecka-Piontek J (2017) Radiolytic studies of cefozopran hydrochloride in the solid state. Electron J Biotechnol 25:28","journal-title":"Electron J Biotechnol"},{"key":"11730_CR62","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/bph.13746","volume":"174","author":"M Zusso","year":"2017","unstructured":"Zusso M, Mercanti G, Belluti F, Di Martino RMC, Pagetta A, Marinelli C, Brun P, Ragazzi E, Lo R, Stifani S, Giusti P, Moro S (2017) Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism. Br J Pharmacol 174:1090","journal-title":"Br J Pharmacol"},{"key":"11730_CR63","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1016\/j.febslet.2008.10.037","volume":"582","author":"N Resman","year":"2008","unstructured":"Resman N, Gradi\u0161ar H, Va\u0161l J, Keber MM, Pristov\u0161ek P, Jerala R (2008) Taxanes inhibit human TLR4 signaling by binding to MD-2. FEBS Lett 582:3929","journal-title":"FEBS Lett"},{"key":"11730_CR64","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1021\/acschemneuro.3c00411","volume":"14","author":"H Xing","year":"2023","unstructured":"Xing H, Zhang S, You M, Yan M, Zhang J, Chen J, Chen Y, Liu X, Zhu J (2023) Thymoquinone alleviates paclitaxel-induced peripheral neuropathy through regulation of the TLR4-MyD88 inflammatory pathway. ACS Chem Neurosci 14:3804","journal-title":"ACS Chem Neurosci"},{"key":"11730_CR65","doi-asserted-by":"publisher","first-page":"e1007228","DOI":"10.1371\/journal.pcbi.1007228","volume":"15","author":"A Tafazzol","year":"2019","unstructured":"Tafazzol A, Duan Y (2019) Key residues in TLR4-MD2 tetramer formation identified by free energy simulations. PLoS Comput Biol 15:e1007228","journal-title":"PLoS Comput Biol"},{"key":"11730_CR66","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1016\/j.bmc.2012.08.022","volume":"20","author":"S Zhang","year":"2012","unstructured":"Zhang S, Cheng K, Wang X, Yin H (2012) Selection, synthesis, and anti-inflammatory evaluation of the arylidene malonate derivatives as TLR4 signaling inhibitors. Bioorg Med Chem 20:6073","journal-title":"Bioorg Med Chem"},{"key":"11730_CR67","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717","journal-title":"Sci Rep"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11730-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:04:33Z","timestamp":1793858673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11730-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":67,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11730"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11730-z","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare that there is no conflict of interest in this work. The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}